Trend in Gastric Cancer Mortality in Kazakhstan

Document Type : Research Articles


1 Astana Medical University, Astana, Kazakhstan.

2 Central Asian Institute for Medical Research, Astana, Kazakhstan.

3 Kyrgyz State Medical Academy named after I. K. Akhunbaev, Bishkek, Kyrgyzstan.

4 Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan.

5 Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan. .

6 Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.

7 Khoja Akhmet Yassawi International Kazakh-Turkish University, Shymkent Campus, Kazakhstan.

8 National Scientific Center of Surgery, Almaty, Kazakhstan.


Objective: The aim is to study the trends in gastric cancer (GC) mortality in Kazakhstan. Methods: Data on those who died from GC and on the annual population were obtained from the Bureau of National Statistics of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan. A retrospective study was carried out for the period 2009-2018 using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific mortality rates are determined according to the generally accepted methodology used in sanitary statistics. Results: GC mortality in Kazakhstan is considered to be decreasing. It was determined that during the studied period 19,672 died of this cancer. The mean of death was 67.8 with 95% CI of 67.6 to 68.0. The highest mortality rates per 100,000 in the entire population were found in the age groups 75-79 years (145.9±24.1), 80-84 years (161.0±11.0), and 85+ years (116.5±16.4). Trends in age-related mortality rates had a pronounced tendency to increase in 70-74 years (T=+4.3%, R2=0.1924) and to decrease in the age of up to 30 (T=−8.7%, R2=0.2426). The average annual standardized mortality rate was 13.2 per 100,000, and in trends   tended to decrease (T=−5.8%; R2=0.9763). In all regions, there is a decrease in mortality, except for the city of Astana. During categorization mortality rates were determined on the basis of standardized indicators: low – up to 12.9, average – from 12.9 to 15.1, high – above 15.1 per 100,000 for the entire population. Conclusion: The mortality rates from GC tend to decrease, while the downward trends and the degree of their approximation are expressed in almost all regions. The study of regional mortality has theoretical and practical significance for monitoring and evaluating the effectiveness of early detection and treatment. Health authorities should take into account the results obtained when organizing antitumor measures.


Main Subjects

Volume 23, Issue 11
November 2022
Pages 3779-3789
  • Receive Date: 25 April 2022
  • Revise Date: 17 August 2022
  • Accept Date: 24 November 2022
  • First Publish Date: 24 November 2022